keyword
https://read.qxmd.com/read/38615359/medical-diagnostic-accuracy-measures-an-innovative-approach-based-on-the-area-under-predictive-values-curves
#1
JOURNAL ARTICLE
Hani Samawi, Jing Kersey, Jingjing Yin, Haresh Rochani
Positive and negative estimates are commonly used by clinicians to evaluate the likelihood of a disease stage being present based on test results. The predicted values are dependent on the prevalence of the underlying illness. However, for certain diseases or clinical conditions, the prevalence is unknown or different from one region to another or from one population to another, leading to an erroneous diagnosis. This article introduces innovative post-test diagnostic precision measures for continuous tests or biomarkers based on the combined areas under the predictive value curves for all possible prevalence values...
April 14, 2024: Journal of Biopharmaceutical Statistics
https://read.qxmd.com/read/38615320/context-dependent-roles-for-ubiquitous-mitochondrial-creatine-kinase-ckmt1-in-breast-cancer-progression
#2
JOURNAL ARTICLE
Vinay Ayyappan, Nicole M Jenkinson, Caitlin M Tressler, Zheqiong Tan, Menglin Cheng, Xinyi Elaine Shen, Alejandro Guerrero, Kanchan Sonkar, Ruoqing Cai, Oluwatobi Adelaja, Sujayita Roy, Alan Meeker, Pedram Argani, Kristine Glunde
Metabolic reprogramming is a hallmark of cancer, enabling cancer cells to rapidly proliferate, invade, and metastasize. We show that creatine levels in metastatic breast cancer cell lines and secondary metastatic tumors are driven by the ubiquitous mitochondrial creatine kinase (CKMT1). We discover that, while CKMT1 is highly expressed in primary tumors and promotes cell viability, it is downregulated in metastasis. We further show that CKMT1 downregulation, as seen in breast cancer metastasis, drives up mitochondrial reactive oxygen species (ROS) levels...
April 12, 2024: Cell Reports
https://read.qxmd.com/read/38615276/educational-level-and-characteristics-of-invasive-breast-cancer-findings-from-a-french-prospective-cohort
#3
JOURNAL ARTICLE
Eloïse Berger, Amandine Gelot, Agnès Fournier, Laure Dossus, Marie-Christine Boutron-Ruault, Gianluca Severi, Raphaële Castagné, Cyrille Delpierre
PURPOSE: Breast cancer (BC) characteristics are known to influence patients survival. Social differences have been reported by previous studies for those characteristics but questions persist because of inconsistent conclusions. We aimed to investigate the impact of education on BC stage, grade, and hormone receptor (HR) status, while adjusting for potential confounders including a broad set of health behaviors, anthropometric measures, and reproductive factors. METHODS: In the French E3N cohort, 5236 women developed a primary invasive BC for which there was available information on stage, grade, and HR status...
April 14, 2024: Cancer Causes & Control: CCC
https://read.qxmd.com/read/38615265/association-between-estrogen-receptor-alpha-and-aryl-hydrocarbon-receptor-gene-polymorphisms-in-the-prognosis-of-breast-cancer-in-egypt
#4
JOURNAL ARTICLE
Sara A Aboelroos, Elsayed H M Eltamany, Faten A M Mohamed, Marwa A Suliman
Breast cancer is the most malignant tumor among women in the world. Single nucleotide polymorphisms (SNPs) might better predict breast cancer prognosis. PvuII (T/C substitution), XbaI (A/G substitution), and aryl hydrocarbon (AhR) (G/A substitution) were evaluated as possible genetic prognostic factors for breast cancer. The aim of the current study was to assess the relation between PvuII (rs2234693), XbaI (rs9340799), and aryl hydrocarbon receptor gene polymorphisms AhR (rs2066853) in breast cancer prognosis...
April 2024: Egyptian Journal of Immunology
https://read.qxmd.com/read/38615212/clinicopathological-significance-of-tumor-budding-in-breast-carcinoma
#5
JOURNAL ARTICLE
Archana Buch, Khushi Jain, Hetal Rathod, Charusheela Gore
BACKGROUND: Tumour budding Tuberculosis is a new prognostic marker whose role in breast cancer is still under evaluation. Our aim was to study Tuberculosis in breast carcinoma and correlate it with other prognostic markers. METHODS: A descriptive cross-sectional study was conducted over 2 years on 75 invasive breast carcinoma specimens and biopsies. Hematoxylin and Eosin sections were examined for tumour grade, stage, molecular subtype, necrosis, lymphovascular invasion inflammation and counting of Tuberculosis...
March 22, 2024: Journal of Nepal Health Research Council
https://read.qxmd.com/read/38615110/unraveling-the-anti-breast-cancer-activity-of-cimicifugae-rhizoma-using-biological-network-pathways-and-molecular-dynamics-simulation
#6
JOURNAL ARTICLE
Prashasti Sinha, Anil Kumar Yadav
Cimicifugae is a commonly used treatment for breast cancer, but the specific molecular mechanisms underlying its effectiveness remain unclear. In this research, we employ a combination of network pharmacology, molecular docking, and molecular dynamics simulations to uncover the most potent phytochemical within Cimicifugae rhizoma in order to delve into its interaction with the target protein in breast cancer treatment. We identified 18 active compounds and 89 associated targets, primarily associated to various biological processes such as lipid metabolism, the signaling pathway in diabetes, viral infections, and cancer-related pathways...
April 13, 2024: Molecular Diversity
https://read.qxmd.com/read/38615059/non-preventable-cases-of-breast-prostate-lung-and-colorectal-cancer-in-2050-in-an-elimination-scenario-of-modifiable-risk-factors
#7
JOURNAL ARTICLE
Frederik Knude Palshof, Lina Steinrud Mørch, Brian Køster, Gerda Engholm, Hans Henrik Storm, Therese M-L Andersson, Niels Kroman
Most Western countries have increasing number of new cancer cases per year. Cancer incidence is primarily influenced by basically avoidable risk factors and an aging population. Through hypothetical elimination scenarios of multiple major risk factors for cancer, we estimated the number of new cancer cases that are non-preventable in 2050. We compare numbers of new postmenopausal breast, prostate, lung, and colorectal cancer cases in 2021 to projected numbers of new cases in 2050 under prevention scenarios regarding smoking, overweight and obesity, and alcohol consumption: no intervention, 50%, and 100% instant reduction...
April 13, 2024: Scientific Reports
https://read.qxmd.com/read/38615057/prediction-of-hematologic-toxicity-in-luminal-type-breast-cancer-patients-receiving-neoadjuvant-chemotherapy-using-ct-l1-level-skeletal-muscle-index
#8
JOURNAL ARTICLE
Min Chen, Pinxiu Wang, Yanting Li, Zhuanmei Jin, Yu An, Yanan Zhang, Wenzhen Yuan
This study aims to explore the correlation between the CT-L1 and L3 body composition parameters and analyze the relationship between L1 body composition and hematologic toxicity in luminal-type breast cancer patients undergoing neoadjuvant chemotherapy. Data from 140 luminal-type breast cancer patients who underwent surgical treatment after neoadjuvant chemotherapy were analyzed retrospectively. Spearman analysis was used to assess the correlation between CT-L1 and CT-L3 body composition parameters pre-neoadjuvant chemotherapy...
April 13, 2024: Scientific Reports
https://read.qxmd.com/read/38614979/racial-ethnic-differences-in-21-gene-recurrence-score-and-survival-among-patients-with-estrogen-receptor-positive-breast-cancer
#9
JOURNAL ARTICLE
Jasmin Gill, Keerti Yendamuri, Udit Chatterjee, Song Yao, Oluwadamilola T Oladeru, Anurag K Singh, Sung Jun Ma
BACKGROUND: Despite numerous studies on racial/ethnic disparities among patients with breast cancer, there is a paucity of literature evaluating racial/ethnic differences in 21-gene recurrence score (RS) and survival differences stratified by RS risk categories. We thus performed an observational cohort study to examine racial/ethnic disparities in the context of RS. METHODS: The National Cancer Database (NCDB) was queried for female patients diagnosed between 2006 and 2018 with estrogen receptor (ER)-positive, pT1-3N0-1aM0 breast cancer who received surgery followed by adjuvant endocrine therapy and had RS data available...
April 13, 2024: BMC Cancer
https://read.qxmd.com/read/38614852/hypofractionation-for-regional-nodal-irradiation-in-breast-cancer-best-of-both-the-worlds
#10
REVIEW
Budhi Singh Yadav, Treshita Dey
Locoregional radiotherapy play an important role in controlling the disease after surgery in patients with breast cancer. Radiotherapy schedules vary from conventional fraction to hypofractionation. The purpose of this review is to get an insight into the data on regional nodal irradiation (RNI) with hypofractionation in patients with breast cancer. This systematic review was constructed in accordance with Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) framework. Electronic databases such as PubMed, Cochrane and EMBASE were searched from January 1, 2023 to March 31, 2023 to identify studies published in English language on hypofractionated RNI in post mastectomy patients...
March 14, 2024: Clinical Breast Cancer
https://read.qxmd.com/read/38614825/use-of-response-permutation-to-measure-an-imaging-dataset-s-susceptibility-to-overfitting-by-selected-standard-analysis-pipelines
#11
JOURNAL ARTICLE
Jayasree Chakraborty, Abhishek Midya, Brenda F Kurland, Mattea L Welch, Mithat Gonen, Chaya S Moskowitz, Amber L Simpson
RATIONALE AND OBJECTIVES: This study demonstrates a method for quantifying the impact of overfitting on the receiving operator characteristic curve (AUC) when using standard analysis pipelines to develop imaging biomarkers. We illustrate the approach using two publicly available repositories of radiology and pathology images for breast cancer diagnosis. MATERIALS AND METHODS: For each dataset, we permuted the outcome (cancer diagnosis) values to eliminate any true association between imaging features and outcome...
April 12, 2024: Academic Radiology
https://read.qxmd.com/read/38614738/hormone-therapy-in-the-management-of-stage-four-asymptomatic-metastatic-breast-cancer-in-women
#12
JOURNAL ARTICLE
Suvam Banerjee
No abstract text is available yet for this article.
November 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614427/a-meta-analysis-of-the-carcinogenic-effects-of-particulate-matter-and-polycyclic-aromatic-hydrocarbons
#13
REVIEW
Irtaqa Arif, Matthew D Adams, Marc T J Johnson
Urbanization has numerous benefits to human society, but some aspects of urban environments, such as air pollution, can negatively affect human health. Two major air pollutants, particulate matter (PM) and polycyclic aromatic hydrocarbons (PAH), have been classified as carcinogens by the International Agency for Research on Cancer. Here, we answer two questions: (1) What are the carcinogenic effects of PM and PAH exposure? (2) How does carcinogenic risk vary across geographical regions? We performed a comprehensive literature search of peer-reviewed published studies examining the link between air pollution and human cancer rates...
April 11, 2024: Environmental Pollution
https://read.qxmd.com/read/38614259/antitumoral-activity-of-different-amaryllidaceae-alkaloids-in-vitro-and-in-silico-assays
#14
JOURNAL ARTICLE
Luciana R Tallini, Gustavo Machado das Neves, Maria Helena Vendruscolo, Paula Rezende-Teixeira, Warley Borges, Jaume Bastida, Letícia V Costa-Lotufo, Vera Lucia Eifler-Lima, José Angelo S Zuanazzi
ETHNOPHARMACOLOGY RELEVANCE: The plants of Amaryllidaceae family, such as Amaryllis belladonna L., have been used as herbal remedies for thousands of years to address various disorders, including diseases that might today be identified as cancer. AIM OF THE STUDY: The objective of this work was to evaluate the potential of three Amaryllidaceae alkaloids against four cancer cell lines. MATERIAL AND METHODS: The alkaloids lycorine, 1-O-acetylcaranine, and montanine were evaluated in vitro against colon adenocarcinoma cell line (HCT-116) and breast carcinoma cell lines (MCF-7, MDAMB231, and Hs578T)...
April 11, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38614151/modification-of-the-phenyl-ring-b-of-phenyl-4-2-oxoimidazolidin-1-yl-benzenesulfonates-by-pyridinyl-moiety-leads-to-novel-antimitotics-targeting-the-colchicine-binding-site
#15
JOURNAL ARTICLE
Vincent Ouellette, Chahrazed Bouzriba, Atziri Corin Chavez Alvarez, Geneviève Hamel-Côté, Sébastien Fortin
A series of 8 novel pyridinyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates (PYRIB-SOs) were designed, prepared and evaluated for their mechanism of action. PYRIB-SOs were found to have antiproliferative activity in the nanomolar to submicromolar range on several breast cancer cell lines. Moreover, subsequent biofunctional assays indicated that the most potent PYRIB-SOs 1-3 act as antimitotics binding to the colchicine-binding site (C-BS) of α, β-tubulin and that they arrest the cell cycle progression in the G2/M phase...
April 11, 2024: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/38614094/a-comprehensive-single-cell-breast-tumor-atlas-defines-epithelial-and-immune-heterogeneity-and-interactions-predicting-anti-pd-1-therapy-response
#16
JOURNAL ARTICLE
Lily Xu, Kaitlyn Saunders, Shao-Po Huang, Hildur Knutsdottir, Kenneth Martinez-Algarin, Isabella Terrazas, Kenian Chen, Heather M McArthur, Julia Maués, Christine Hodgdon, Sangeetha M Reddy, Evanthia T Roussos Torres, Lin Xu, Isaac S Chan
We present an integrated single-cell RNA sequencing atlas of the primary breast tumor microenvironment (TME) containing 236,363 cells from 119 biopsy samples across eight datasets. In this study, we leverage this resource for multiple analyses of immune and cancer epithelial cell heterogeneity. We define natural killer (NK) cell heterogeneity through six subsets in the breast TME. Because NK cell heterogeneity correlates with epithelial cell heterogeneity, we characterize epithelial cells at the level of single-gene expression, molecular subtype, and 10 categories reflecting intratumoral transcriptional heterogeneity...
April 9, 2024: Cell reports medicine
https://read.qxmd.com/read/38614086/genomic-deletions-explain-the-generation-of-alternative-braf-isoforms-conferring-resistance-to-mapk-inhibitors-in-melanoma
#17
JOURNAL ARTICLE
Francisco Aya, Pablo Lanuza-Gracia, Abel González-Pérez, Sophie Bonnal, Estefania Mancini, Nuria López-Bigas, Ana Arance, Juan Valcárcel
Resistance to MAPK inhibitors (MAPKi), the main cause of relapse in BRAF-mutant melanoma, is associated with the production of alternative BRAF mRNA isoforms (altBRAFs) in up to 30% of patients receiving BRAF inhibitor monotherapy. These altBRAFs have been described as being generated by alternative pre-mRNA splicing, and splicing modulation has been proposed as a therapeutic strategy to overcome resistance. In contrast, we report that altBRAFs are generated through genomic deletions. Using different in vitro models of altBRAF-mediated melanoma resistance, we demonstrate the production of altBRAFs exclusively from the BRAF V600E allele, correlating with corresponding genomic deletions...
April 9, 2024: Cell Reports
https://read.qxmd.com/read/38614071/thermo-immune-synergy-camrelizumab-plus-microwave-ablation-in-preoperative-early-stage-breast-cancer
#18
JOURNAL ARTICLE
Yu-Ling Xiao, Song-Yang Wu, Yi-Zhou Jiang
Immunotherapy has enhanced breast cancer outcomes, but optimizing combination therapies is crucial. Integrating additional treatment modalities, like physical therapies, holds promise for optimizing efficacy. Pan et al. recently reported that combining preoperative immunotherapy with microwave ablation is safe and feasible in early-stage breast cancer, effectively sensitizing peripheral CD8+ T cells.1 .
April 12, 2024: Med
https://read.qxmd.com/read/38614043/natural-products-and-derivatives-for-breast-cancer-treatment-from-drug-discovery-to-molecular-mechanism
#19
REVIEW
Jing Zhang, Yongya Wu, Yanhong Li, Shutong Li, Jiaxi Liu, Xiao Yang, Guiyang Xia, Guan Wang
BACKGROUND: Breast cancer stands as the most common malignancy among women globally and a leading cause of cancer-related mortality. Conventional treatments, such as surgery, hormone therapy, radiotherapy, chemotherapy, and small-molecule targeted therapy, often fall short of addressing the complexity and heterogeneity of certain breast cancer subtypes, leading to drug resistance and metastatic progression. Thus, the search for novel therapeutic targets and agents is imperative. Given their low toxicity and abundant variety, natural products and their derivatives are increasingly considered valuable sources for small-molecule anticancer drugs...
April 7, 2024: Phytomedicine
https://read.qxmd.com/read/38613998/therapeutic-vulnerabilities-in-triple-negative-breast-cancer-stem-like-traits-explored-within-molecular-classification
#20
REVIEW
Peng Huang, Xi Zhang, Jyothi S Prabhu, Vijay Pandey
Triple Negative Breast Cancer (TNBC) is the most aggressive type of breast cancer (BC). Despite advances in the clinical management of TNBC, recurrence-related mortality remains a challenge. The stem-like phenotype of TNBC plays a significant role in the persistence of minimal disease residue after therapy. Individuals exhibiting stem-like characteristics are particularly prone to inducing malignant relapse accompanied by strong resistance. Therefore, stem-like traits have been broadly proposed as therapeutic vulnerabilities to treat TNBC and reduce recurrence...
April 12, 2024: Biomedicine & Pharmacotherapy
keyword
keyword
103
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.